{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:51:38Z","timestamp":1761173498536,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.purol.2014.01.002","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T10:00:21Z","timestamp":1392026421000},"page":"588-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Traitement de l\u2019incontinence urinaire masculine non neurologique par hyperactivit\u00e9 v\u00e9sicale\u00a0: une revue de la litt\u00e9rature du CTMH de l\u2019AFU"],"prefix":"10.1016","volume":"24","author":[{"given":"S.","family":"Lebdai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Haillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Azzouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Benchikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Campeggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-N.","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.B.","family":"Delongchamps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Dumonceau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Faix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fourmarier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lukacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Misrai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"de La Taille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Descazeaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2014.01.002_bib0005","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.eururo.2011.01.031","article-title":"The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study","volume":"59","author":"Vaughan","year":"2011","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.purol.2014.01.002_bib0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.eururo.2010.11.021","article-title":"EAU guidelines on urinary incontinence","volume":"59","author":"Thuroff","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0020","doi-asserted-by":"crossref","first-page":"c2354","DOI":"10.1136\/bmj.c2354","article-title":"Management of lower urinary tract symptoms in men: summary of NICE guidance","volume":"340","author":"Jones","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.purol.2014.01.002_bib0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.purol.2013.02.001","article-title":"[Pharmacological treatment of idiopathic overactive bladder: a literature review]","volume":"23","author":"Cornu","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0030","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","article-title":"The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis","volume":"54","author":"Chapple","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0035","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.eururo.2012.08.060","article-title":"Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses","volume":"62","author":"Buser","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2014.01.002_bib0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/nau.20844","article-title":"Surgical treatment of stress incontinence in men","volume":"29","author":"Herschorn","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2014.01.002_bib0045","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1464-410X.2006.06068.x","article-title":"Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence","volume":"97","author":"Roehrborn","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.01.002_bib0050","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.purol.2014.01.002_bib0055","article-title":"Drug class review: agents for overactive bladder: final report update 4 [Internet]","author":"McDonagh","year":"2009","journal-title":"Drug Class Rev"},{"key":"10.1016\/j.purol.2014.01.002_bib0060","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/00912700122010528","article-title":"Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system","volume":"41","author":"Todorova","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.purol.2014.01.002_bib0065","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2008.06.080","article-title":"A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder","volume":"54","author":"Novara","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0070","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/j.1532-5415.2011.03724.x","article-title":"Behavioral versus drug treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial","volume":"59","author":"Burgio","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.purol.2014.01.002_bib0075","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1464-410X.2009.08910.x","article-title":"Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study","volume":"105","author":"Mattiasson","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.01.002_bib0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0090-4295(90)80078-2","article-title":"Functional evaluation of sacral nerve root integrity. Report of a technique","volume":"35","author":"Schmidt","year":"1990","journal-title":"Urology"},{"key":"10.1016\/j.purol.2014.01.002_bib0085","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/01.ju.0000092634.64580.9a","article-title":"New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience","volume":"170","author":"Spinelli","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0090","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-5347(05)00326-5","article-title":"Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review","volume":"175","author":"Brazzelli","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0095","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.juro.2011.04.059","article-title":"Sacral neuromodulation as treatment for refractory idiopathic urge urinary incontinence: 5-year results of a longitudinal study in 60\u00a0women","volume":"186","author":"Groen","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0100","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.juro.2007.07.032","article-title":"Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study","volume":"178","author":"van Kerrebroeck","year":"2007","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.purol.2014.01.002_bib0105","first-page":"CD004202","article-title":"Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults","author":"Herbison","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.purol.2014.01.002_bib0110","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.purol.2012.08.272","article-title":"[Botulinum toxin injections: a new therapeutic avenue in urology]","volume":"22","author":"Karsenty","year":"2012","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0115","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.purol.2013.10.006","article-title":"[Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management]","volume":"23","author":"Hermieu","year":"2013","journal-title":"Prog Urol"},{"issue":"12","key":"10.1016\/j.purol.2014.01.002_bib0120","first-page":"CD005493","article-title":"Botulinum toxin injections for adults with overactive bladder syndrome","author":"Duthie","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.purol.2014.01.002_bib0125","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2011.07.001","article-title":"Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)","volume":"60","author":"Mangera","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0130","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/nau.21054","article-title":"Bladder base\/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor over-activity refractory to antimuscarinics","volume":"30","author":"Kuo","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2014.01.002_bib0135","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.juro.2008.08.030","article-title":"Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population","volume":"180","author":"White","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0140","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2011.10.028","article-title":"Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study","volume":"61","author":"Denys","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0145","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2011.12.011","article-title":"Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates","volume":"61","author":"Dowson","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/003655901750291944","article-title":"Clam ileocystoplasty: successful treatment of severe bladder over-activity","volume":"35","author":"Edlund","year":"2001","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.purol.2014.01.002_bib0155","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1464-410x.1998.00549.x","article-title":"Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women","volume":"81","author":"Awad","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.purol.2014.01.002_bib0160","first-page":"CD003306","article-title":"Urinary diversion and bladder reconstruction\/replacement using intestinal segments for intractable incontinence or following cystectomy","volume":"2","author":"Cody","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.purol.2014.01.002_bib0165","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1464-4096.2001.001206","article-title":"Augmentation cystoplasty","volume":"88","author":"Greenwell","year":"2001","journal-title":"BJU Int"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708714000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708714000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:24:42Z","timestamp":1761114282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708714000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1166708714000190"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2014.01.002","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement de l\u2019incontinence urinaire masculine non neurologique par hyperactivit\u00e9 v\u00e9sicale\u00a0: une revue de la litt\u00e9rature du CTMH de l\u2019AFU","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2014.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}